. . . . . . . . "60%"@en . "A potent and specific HIV protease inhibitor that appears to have good oral bioavailability. [PubChem]"@en . . . "Less than 20% of indinavir is excreted unchanged in the urine."@en . "Symptoms of overdose include myocardial infarction and angina pectoris."@en . . . . . "Indinavir inhibits the HIV viral protease enzyme which prevents cleavage of the gag-pol polyprotein, resulting in noninfectious, immature viral particles."@en . . . . . . . "150378-17-9"@en . . . . . . . . . "Avoid excessive or chronic alcohol use."@en . "Take with a full glass of water."@en . . . . . . . "(1(1S,2R),5(S))-2,3,5-Trideoxy-N-(2,3-dihydro-2-hydroxy-1H-inden-1-yl)-5-(2-(((1,1-dimethylethyl)amino)carbonyl)-4-(3-pyridinylmethyl)-1-piperazinyl)-2-(phenylmethyl)-D-erythro-pentonamide"@en . . . . . . . . . . "Indinavir"@en . . . . . . . . "Indinavir is an antiretroviral drug for the treatment of HIV infection."@en . . "Indinavir"@en . "approved"@en . . "Avoid taking with grapefruit juice"@en . "Human Immunodeficiency Virus"@en . . . . "Rapidly absorbed"@en . . " "@en . . . . "\"DrugSyn.org\":http://www.drugsyn.org/Indinavir.htm"@en . . . "1.8 (± 0.4) hours"@en . . . . . . . "Take on empty stomach: 1 hour before or 2 hours after meals."@en .